Title of article
Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register Original Research Article
Author/Authors
Bernadette Modell، نويسنده , , Maren Khan، نويسنده , , Matthew Darlison، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2000
Pages
2
From page
2051
To page
2052
Abstract
About 50% of UK patients with β-thalassaemia major die before the age of 35 years, mainly because conventional iron-chelation therapy is too burdensome for full adherence. Patients require an idividually-tailored treatment plan incorporating new, more tolerable approaches.
Journal title
The Lancet
Serial Year
2000
Journal title
The Lancet
Record number
552117
Link To Document